These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12672400)

  • 1. Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy.
    Ye P; Kourtis AP; Kirschner DE
    Clin Immunol; 2003 Feb; 106(2):95-105. PubMed ID: 12672400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
    Amado RG; Jamieson BD; Cortado R; Cole SW; Zack JA
    J Virol; 1999 Aug; 73(8):6361-9. PubMed ID: 10400728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.
    Hardy G; Worrell S; Hayes P; Barnett CM; Glass D; Pido-Lopez J; Imami N; Aspinall R; Dutton J; Gazzard B; Peters AM; Gotch FM
    HIV Med; 2004 Mar; 5(2):67-73. PubMed ID: 15012644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
    Vigano A; Vella S; Saresella M; Vanzulli A; Bricalli D; Di Fabio S; Ferrante P; Andreotti M; Pirillo M; Dally LG; Clerici M; Principi N
    AIDS; 2000 Feb; 14(3):251-61. PubMed ID: 10716501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue.
    Talal AH; Monard S; Vesanen M; Zheng Z; Hurley A; Cao Y; Fang F; Smiley L; Johnson J; Kost R; Markowitz MH
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):1-7. PubMed ID: 11176263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml.
    Easterbrook PJ; Ives N; Waters A; Mullen J; O'Shea S; Peters B; Gazzard BG
    AIDS; 2002 Jul; 16(11):1521-7. PubMed ID: 12131190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness.
    Ometto L; De Forni D; Patiri F; Trouplin V; Mammano F; Giacomet V; Giaquinto C; Douek D; Koup R; De Rossi A
    AIDS; 2002 Apr; 16(6):839-49. PubMed ID: 11919485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection.
    Vallejo A; Valladares A; De Felipe B; Vivancos J; Gutierrez S; Soriano-Sarabia N; Ruiz-Mateos E; Lissen E; Leal M
    Viral Immunol; 2005; 18(4):740-6. PubMed ID: 16359240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic selective treatment in highly pre-treated HIV patients harbouring multiply resistant viruses.
    Maggiolo F; Callegaro A; Gregis G; Quinzan G; Ripamonti D; Arici C; Goglio A; Suter F
    AIDS; 2002 Jan; 16(2):298-9. PubMed ID: 11807319
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.
    Stoddart CA; Liegler TJ; Mammano F; Linquist-Stepps VD; Hayden MS; Deeks SG; Grant RM; Clavel F; McCune JM
    Nat Med; 2001 Jun; 7(6):712-8. PubMed ID: 11385509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thymus during HIV disease: role in pathogenesis and in immune recovery.
    Ye P; Kirschner DE; Kourtis AP
    Curr HIV Res; 2004 Apr; 2(2):177-83. PubMed ID: 15078181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.
    Rodriguez CA; Koch S; Goodenow M; Sleasman JW
    Immunol Res; 2008; 40(3):271-86. PubMed ID: 17952387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.
    Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A
    AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher antiviral activity of antiretroviral regimens including protease inhibitors.
    de Mendoza C; Soriano V; Rodríguez-Rosado R; González-Lahoz J
    AIDS; 1999 May; 13(8):998-9. PubMed ID: 10371186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.